Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors

Abstract

Our objectives were to examine the prevalence of work disability (WD) and factors associated with job loss in systemic lupus erythematosus (SLE) in a large, multi-centered Canadian sample to determine the current prevalence of WD and identify the contribution of disease activity, damage, and co-morbidities with respect to WD in this cohort. Cross-sectional data on WD status from the 1000 Canadian Faces of Lupus database (a multi-center multi-ethnic cohort of SLE patients) along with clinical measures (number of ACR criteria ever, SLICC Damage Index, SLAM, SLEDAI, SF-36 and Charlson Co-morbidity Index scores), demographic features (age, sex, high school education, household income, marital status, disease duration, employment status) and co-morbidities (including self-reported fibromyalgia, arthralgias, depression and fatigue) were used in bivariate and logistic regression analyses. The 1137 SLE patients had a mean age of 50 years (SE 0.75) and mean disease duration was 18 years (SE 0.70); 19.09% were work disabled and 49.78% were employed. Those with WD were more likely than non-WD SLE patients to have: a higher number of ACR criteria for SLE; not completed high school; older age; single marital status; a lower household income; longer disease duration; higher SLICC Damage Index and SLAM scores; lower SF-36 PCS and SF-36 MCS scores; less vigorous activity per week; and fibromyalgia, arthralgias, fatigue and depression (p < 0.05). This contemporary rate of WD is lower than many past reports. Socio-demographic factors, co-morbidities (fibromyalgia and fatigue) and disease related factors were strongly associated with WD. We cannot determine cause and effect as the study was cross-sectional. Lupus (2009) 18, 1281—1288.

Keywords

1000 Faces of Lupus Canadian Network for Improved Outcomes in SLE (CaNIOS)employment systemic lupus erythematosus (SLE)work disability (WD)

Get full access to this article

View all access options for this article.

References

Bertoli AM , Fernandez M. , Alarcon GS , Vila LM , Reveille JD Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability. Ann Rheum Dis 2007; 66: 12-17.

Huang HC , Chou CT , Lin KC , Chao YF The relationships between disability level, health-promoting lifestyle, and quality of life in outpatients with systemic lupus erythematosus. J Nurs Res 2007; 15: 21-32.

Merkel P. Systemic lupus erythematosus. In: Andreoli C , (ed), Essentials of Medicine, 6th edn. Philadelphia, PA: Elsevier ; 2004. p. 745.

Stamm TA , Bauernfeind B. , Coenen M. , et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status . Arthritis Rheum 2007; 57: 1287-1295.

Yelin E. , Trupin L. , Katz P. , et al. Work dynamics among persons with systemic lupus erythematosus . Arthritis Rheum 2007; 57: 56-63.

Partridge AJ , Karlson EW , Daltroy LH , et al. Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum 1997; 40: 2199-2206.

Panopalis P. , Petri M. , Manzi S. , et al, the Tri-Nation Study Group. The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs. Arthritis Rheum 2007; 57: 64-70.

Lacaille D. Arthritis and employment research: Where are we? Where do we need to go? J Rheumatol Suppl 2005; 72: 42-45. 9 Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum 2008; 59: 136-143.

Jönsson G. , Sjöholm AG , Truedsson L. , Bengtsson AA , Braconier JH , Sturfelt G. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency . Rheumatology (Oxford) 2007; 46: 1133-1139.

10.

Nived O. , Andersson M. , Lindgren M. , et al. Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: a study with a questionnaire. Lupus 2007; 16: 701-706.

11.

Utset TO , Fink J. , Doninger NA Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol 2006; 33: 531-538.

12.

Boomsma MM , Bijl M. , Stegeman CA , Kallenberg CG , Hoffman GS , Tervaert JW Patients’ perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener’s granulomatosis. Arthritis Rheum 2002; 47: 196-201.

13.

Jönsen A. , Bengtsson AA , Nived O. , Ryberg B. , Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology ( Oxford) 2002; 41: 1308-1312.

14.

Sutcliffe N. , Clarke AE , Taylor R. , Frost C. , Isenberg DA Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology ( Oxford) 2001; 40: 37-47.

15.

Clarke AE , Penrod J. , St Pierre Y. , et al. Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group. J Rheumatol 2000; 27: 2597-2604.

16.

Murphy NG , Koolvisoot A. , Schumacher HR , Von Feldt JM , Callegari PE Musculoskeletal features in systemic lupus erythematosus and their relationship with disability. J Clin Rheumatol 1998; 4: 238-245.

17.

Middleton GD , McFarlin JE , Lipsky PE The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus . Arthritis Rheum 1994; 37: 1181-1188.

18.

Baker K. , Pope J. Work disability in systemic lupus erythematosus: A systematic review . Rheumatology (Oxford) 2009; 48(3): 281-4 [Epub 2009 Jan 19].

19.

Tan EM , Cohen AS , Fries JF , et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.

20.

Liang MH , Socher SA , Larson MG , Schur PH Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-1118.

21.

Gladman D. , Urowitz M. The SLICC/ACR damage index: Progress report and experience in the field. Lupus 1999; 8: 632-637.

22.

Ware Je Jr , Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998; 51: 903-912.

23.

Charlson ME , Pompei P. , Ales KL , MacKenzie CR A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.

24.

National Academy of Sciences, Committee on Occupational Classification and Analysis. Dictionary of Occupational Titles (DOT): Part I-Current Population Survey, 1971, Augmented with DOT Characteristics, and Part II-Fourth Edition Dictionary of DOT Scores for 1970 census categories. Washington, DC: U.S. Department of Labor, 1997.

25.

Fishbain DA , Cutler RB , Rosomoff H. , Khalil T. , Abdel-Moty E. , Steele-Rosomoff R. Validity of the dictionary of occupational titles residual functional capacity battery . Clin J Pain 1999; 15: 102-110.

26.

Statistics Canada. 2006. Occupation-National Occupational Classification for Statistics 2006 (720), Class of Worker (6) and Sex (3) for the Labour Force 15 Years and Over of Canada, Provinces, Territories, Census Metropolitan Areas and Census Agglomerations, 2006 Census.

27.

Statistics Canada. 2009. Table 282-0003-Labour force survey estimates (LFS)-Employment rate, by educational attainment (all levels), sex (female) and age group (15 and over; 25 and over), unadjusted for seasonality (April 2008-April 2009).

28.

Lacaille D. , Clarke AE , Bloch DA , Danoff D. , Esdaile JM The impact of disease activity, treatment and disease severity on short-term costs of systemic lupus erythematosus. J Rheumatol 1994; 21: 448-453.

29.

Yelin E. Cost of musculoskeletaldiseases: impact of work disability and functional decline. J Rheumatol Suppl 2003; 68: 8-11.

30.

Mau W. , Listing J. , Huscher D. , Zeidler H. , Zink A. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005 ; 32: 721-728.

31.

Clarke AE , Esdaile JM , Bloch DA , Lacaille D. , Danoff DS , Fries JF A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum 1993; 36: 1548-1559.